SCHEMBL3571600

SCHEMBL3571600

CCNc1ccc(Cl)cc1C(=O)N(CCc1cccc(C(F)(F)F)c1)Cc1ccc(C(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
CNR1 P21554 1/20 0.39
HSPH1 Q92598 1/20 0.39
MPO P05164 1/20 0.39
C5AR1 P21730 1/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC11 Q96DB2 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CETP P11597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3583512 0.92 LMNA (0.41) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3575609 0.91 LMNA (0.43) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3580626 0.91 LMNA (0.40) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3570289 0.90 LMNA (0.40) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3583318 0.90 HSPH1 (0.44) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3578904 0.90 LMNA (0.44) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3585675 0.89 LIPC (0.46) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3581190 0.89 TRPV1 (0.41) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3571486 0.89 LMNA (0.41) LMNAHPGDSMN1; SMN2MEN1CYP1A2
SCHEMBL3577493 0.88 LMNA (0.40) LMNAHPGDSMN1; SMN2MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
EP-1984340-B1 ANTHRANILAMIDE/2-AMINO-HETEROARENE CARBOXAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2012-06-27 EP disclosed